Market Overview:
The global skin ulcers anti-infectives products market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of skin ulcers, rising awareness about skin ulcer treatments, and growing demand for advanced therapies and products. In addition, the increasing prevalence of diabetes and other chronic diseases is also contributing to the growth of this market. On the basis of type, the global skin ulcers anti-infectives products market can be segmented into pressure ulcer, diabetic ulcer, venous ulcer, arterial ulcer, and others. The pressure Ulcer segment is expected to account for a major share of this market in 2018 owing to its high prevalence across all regions. On the basis on application,, hospitals are expected account for a major share fo this marke in 2018 followed by clinics .
Product Definition:
Skin ulcers are a common and potentially serious skin condition. They can be caused by a variety of factors, including infection, injury, or autoimmune disorders. Skin ulcers are typically characterized by an open sore on the skin that does not heal quickly. Left untreated, skin ulcers can lead to serious health complications.
Skin ulcer anti-infectives products are used to treat and prevent infection in skin ulcers. These products help reduce the risk of infection-related complications and promote healing.
Pressure Ulcer:
Pressure ulcers are also known as bed sores or pressure sores. They are caused by prolonged exposure to elevated body temperature (38oC - 40oC) and low blood flow. Pressure ulcers can occur anywhere on the body, but they most commonly affect people aged 60 years and above.
Diabetic Ulcer:
Diabetic ulcer is a type of skin wound caused due to diabetes. It is also known as foot ulcer or sugar foot and it affects mostly the patients suffering from diabetes mellitus. The major symptoms associated with this disease are severe pain in the part of feet, swelling, redness, and heat at the site of injury along with frequent changes in shape and size of feet.
Application Insights:
The others application segment held the largest share of more than 60.0% in 2017. The other applications include military, institutional and home care settings among others. Skin ulcers are a common occurrence in hospitals due to high patient admissions with conditions such as diabetes, pressure ulcers and venous leg ulcers being the most prevalent types of skin injuries found in hospitals globally. Pressure ulcer is one of the most common types of skin injuries that occur in hospital beds across the globe owing to prolonged pressure on tender areas resulting into open wounds over a period of time which may take weeks or months to heal completely.
Venous leg ulcer is another type that occurs due Ulcerative Colitis (UC) or Crohn¢â‚¬â„¢s disease which usually affects people aged 30 years.
Regional Analysis:
North America dominated the global skin ulcers anti-infectives products market in 2017. Rising incidence of pressure ulcers, coupled with a growing aging population and increasing healthcare expenditure, are some of the major factors contributing to market growth. In addition, technological advancements such as digital imaging and wound care management have also improved patient outcomes resulting in an increased demand for these products over the forecast period.
Asia Pacific is expected to be one of the fastest growing regions during the forecast period owing to rising healthcare expenditure and improving economic conditions especially in India & China which has resulted into high unmet clinical needs along with huge opportunities for new players coming into this space over next eight years from 2018 till 2030 time frame.
Growth Factors:
- Increasing incidence of skin ulcers due to various reasons such as diabetes, venous leg ulcers, and pressure ulcers
- Growing awareness about the availability and benefits of anti-infectives products for the treatment of skin ulcers
- Rising demand for advanced and innovative anti-infectives products for the treatment of skin ulcers
- Increasing number of research and development activities focused on the development of novel anti-infectives products for the treatment of skin ulcers
- Growing number of partnerships and collaborations between pharmaceutical companies to develop novel anti-infectives products for the treatment or prevention if skin Ulcer
Scope Of The Report
Report Attributes
Report Details
Report Title
Skin Ulcers Anti-Infectives Products Market Research Report
By Type
Pressure Ulcer, Diabetic Ulcer, Venous Ulcer, Arterial Ulcer,
By Application
Hospitals, Clinics, Others,
By Companies
Smith & Nephew, Mölnlycke Health Care, B. Braun, Convatec Group, Coloplast, Integra Lifesciences, 3M, Cardinal Health, Medtronic, Mimedx Group, Mpm Medical, Paul Hartmann, Acelity L.P.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Skin Ulcers Anti-Infectives Products Market Report Segments:
The global Skin Ulcers Anti-Infectives Products market is segmented on the basis of:
Types
Pressure Ulcer, Diabetic Ulcer, Venous Ulcer, Arterial Ulcer,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smith & Nephew
- Mölnlycke Health Care
- B. Braun
- Convatec Group
- Coloplast
- Integra Lifesciences
- 3M
- Cardinal Health
- Medtronic
- Mimedx Group
- Mpm Medical
- Paul Hartmann
- Acelity L.P.
Highlights of The Skin Ulcers Anti-Infectives Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pressure Ulcer
- Diabetic Ulcer
- Venous Ulcer
- Arterial Ulcer
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Skin Ulcers Anti-Infectives Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Skin ulcers anti-infectives products are a type of medication that is used to treat skin ulcers. These products work by preventing or treating infections that may be causing the skin ulcer.
Some of the major companies in the skin ulcers anti-infectives products market are Smith & Nephew, MƒÂ¶lnlycke Health Care, B. Braun, Convatec Group, Coloplast, Integra Lifesciences, 3M, Cardinal Health, Medtronic, Mimedx Group, Mpm Medical, Paul Hartmann, Acelity L.P..
The skin ulcers anti-infectives products market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Skin Ulcers Anti-Infectives Products Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Skin Ulcers Anti-Infectives Products Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Skin Ulcers Anti-Infectives Products Market - Supply Chain
4.5. Global Skin Ulcers Anti-Infectives Products Market Forecast
4.5.1. Skin Ulcers Anti-Infectives Products Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Skin Ulcers Anti-Infectives Products Market Size (000 Units) and Y-o-Y Growth
4.5.3. Skin Ulcers Anti-Infectives Products Market Absolute $ Opportunity
5. Global Skin Ulcers Anti-Infectives Products Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Type
5.3.1. Pressure Ulcer
5.3.2. Diabetic Ulcer
5.3.3. Venous Ulcer
5.3.4. Arterial Ulcer
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Skin Ulcers Anti-Infectives Products Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Skin Ulcers Anti-Infectives Products Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Skin Ulcers Anti-Infectives Products Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Skin Ulcers Anti-Infectives Products Demand Share Forecast, 2019-2026
9. North America Skin Ulcers Anti-Infectives Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Type
9.7.1. Pressure Ulcer
9.7.2. Diabetic Ulcer
9.7.3. Venous Ulcer
9.7.4. Arterial Ulcer
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Skin Ulcers Anti-Infectives Products Demand Share Forecast, 2019-2026
10. Latin America Skin Ulcers Anti-Infectives Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Type
10.7.1. Pressure Ulcer
10.7.2. Diabetic Ulcer
10.7.3. Venous Ulcer
10.7.4. Arterial Ulcer
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Skin Ulcers Anti-Infectives Products Demand Share Forecast, 2019-2026
11. Europe Skin Ulcers Anti-Infectives Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Type
11.7.1. Pressure Ulcer
11.7.2. Diabetic Ulcer
11.7.3. Venous Ulcer
11.7.4. Arterial Ulcer
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Skin Ulcers Anti-Infectives Products Demand Share, 2019-2026
12. Asia Pacific Skin Ulcers Anti-Infectives Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Type
12.7.1. Pressure Ulcer
12.7.2. Diabetic Ulcer
12.7.3. Venous Ulcer
12.7.4. Arterial Ulcer
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Skin Ulcers Anti-Infectives Products Demand Share, 2019-2026
13. Middle East & Africa Skin Ulcers Anti-Infectives Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Skin Ulcers Anti-Infectives Products Market Size and Volume Forecast by Type
13.7.1. Pressure Ulcer
13.7.2. Diabetic Ulcer
13.7.3. Venous Ulcer
13.7.4. Arterial Ulcer
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Skin Ulcers Anti-Infectives Products Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Skin Ulcers Anti-Infectives Products Market: Market Share Analysis
14.2. Skin Ulcers Anti-Infectives Products Distributors and Customers
14.3. Skin Ulcers Anti-Infectives Products Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Smith & Nephew
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mölnlycke Health Care
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B. Braun
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Convatec Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Coloplast
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Integra Lifesciences
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. 3M
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cardinal Health
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medtronic
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Mimedx Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Mpm Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Paul Hartmann
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Acelity L.P.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
